Wells Fargo’s Allergan plc AGN Stock Holding History

Wells Fargo’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,000	Closed	-$3K	–	7228
2020 Q1	$3K	Sell	1,000 -20,000	-95%	-$3.77M	﹤0.01%	5972
2019 Q4	$10K	Sell	21,000 -250,100	-92%	-$45.1M	﹤0.01%	5905
2019 Q3	$739K	Buy	271,100 +231,700	+588%	+$37.7M	﹤0.01%	4080
2019 Q2	$403K	Buy	+39,400	New	+$5.46M	﹤0.01%	4528
2018 Q3	–	Sell	-600	Closed	-$1K	–	6703
2018 Q2	$1K	Buy	+600	New	+$96.3K	﹤0.01%	6283
2017 Q1	–	Sell	-100,000	Closed	-$1.66M	–	6628
2016 Q4	$1.66M	Hold	100,000	–	–	﹤0.01%	3301
2016 Q3	$1.21M	Hold	100,000	–	–	﹤0.01%	3355
2016 Q2	$1.86M	Sell	100,000 -25,000	-20%	-$5.76M	﹤0.01%	3033
2016 Q1	$4.24M	Sell	125,000 -165,000	-57%	-$47.2M	﹤0.01%	2407
2015 Q4	$141K	Hold	290,000	–	–	﹤0.01%	4690
2015 Q3	$5.02M	Buy	290,000 +42,800	+17%	+$13.1M	﹤0.01%	2324
2015 Q2	$2.23M	Buy	247,200 +245,000	+11,136%	+$73.1M	﹤0.01%	3015
2015 Q1	$13K	Hold	2,200	–	–	﹤0.01%	5545
2014 Q4	$25K	Buy	+2,200	New	+$550K	﹤0.01%	5269
2014 Q3	–	Sell	-175,200	Closed	-$39.1M	–	6430
2014 Q2	$39.1M	Hold	175,200	–	–	0.02%	900
2014 Q1	$779K	Buy	175,200 +20,000	+13%	+$3.96M	﹤0.01%	3640
2013 Q4	$670K	Buy	+155,200	New	+$24.3M	﹤0.01%	3659
2013 Q3	–	Sell	-126,100	Closed	-$586K	–	5927
2013 Q2	$586K	Buy	+126,100	New	+$14.3M	﹤0.01%	3600

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Wells Fargo's AGN Position: Q2 2020 in Review

Wells Fargo sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,419,011 shares — an estimated $251M sold.

Wells Fargo first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $665M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Wells Fargo reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Wells Fargo sold 1,419,011 Allergan plc shares in Q2 2020, an estimated $251M.
Wells Fargo first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
Wells Fargo's Allergan plc position peaked at $665M in Q3 2015.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wells Fargo's 13F filing for Q2 2020, filed 13 Aug 2020.